www.prnewswire.com ARS Pharmaceuticals Faces Securities Class Action Over Share Price Collapse
Article Content
- •ARS Pharmaceuticals faces a class action lawsuit for misleading investors.
- •Shares dropped 23.9% following a negative announcement about CVS coverage.
- •Investors have until October 5, 2026, to join the lawsuit.
ARS Pharmaceuticals Inc. is facing a securities class action lawsuit due to alleged misleading disclosures regarding CVS Caremark's coverage for its product, neffy. The lawsuit claims that between March 9 and June 24, 2026, the company misled investors about the timeline for expanded coverage, which led to a significant drop in share price. On June 24, 2026, ARS announced that no new commercial formulary additions had been made for neffy, resulting in a 23.9% decline in share price from $10.54 to $8.02. The lawsuit alleges that investors were not adequately informed about the risks of a delay in coverage until January 2027. Investors have until October 5, 2026, to seek lead plaintiff status in the class action. The case is pending in the United States District Court for the Southern District of California.
Ask AI about this cluster
Answers cite the sources they use
Timeline
More articles in this cluster (3)
Continue Reading
Critical Zero-Day Vulnerability in Cisco Secure Email Gateway Exploited On September 14, 2026, Cisco disclosed a critical SQL injection vulnerability (CVE-2026-76461) in its Secure Email Gateway, allowing unauthenticated remote attackers to execute arbitrary commands with root privileges. This vulnerability arises from insufficient validation in the email parsing logic. Cisco confirmed… 
Critical GitLab CVE-2026-85706 Exploited; Microsoft Issues Record 974 Patches A critical CVE-2026-85706 path-traversal vulnerability in GitLab (CVSS 10.0) was exploited in the wild just hours after its disclosure on September 12, 2026. Microsoft released its largest-ever patch batch, addressing 974 vulnerabilities, including several actively exploited Windows flaws. The GitLab flaw allows…